Kinfo
Azenta, Inc. logo

Azenta, Inc.

AZTANASDAQHealthcare·US · USD
$25.36
-0.06 (-0.24%)
Prices as of July 10, 2026 · market closed

Price

Key statistics

Valuation
Market cap1.17B USD
Enterprise value846.87M USD
Trailing P/E31.69
Forward P/E41.40
PEG ratio0.11
Price / sales1.96
Price / book0.75
Profitability
Gross margin42.84%
Operating margin-10.56%
Profit margin-29.06%
Return on assets-0.64%
Return on equity-6.81%
Income (TTM)
Revenue596.48M USD
Gross profit264.42M USD
EBITDA190.06M USD
Net income-110.89M USD
Diluted EPS-$2.41
Rev. growth (YoY)1.00%
Balance sheet
Total cash380.52M USD
Total debt55.71M USD
Debt / equity3.58
Current ratio2.83
Book value / share$33.73
Cash flow (TTM)
Operating cash flow62.34M USD
Levered free cash flow101.33M USD
Shares & price
Shares outstanding46.09M
Float40.60M
Held by institutions116.89%
Beta1.37
50-day MA$22.20
200-day MA$28.31
52-week high$41.73
52-week low$15.93
Dividends
Forward rate
$0.40
Yield
1.58%
Payout ratio
0.00%
Frequency
Quarterly
Recent payments
  • 2021-12-02$0.10
Earnings (EPS)
DateEst.ActualSurprise2026-05-050.14-0.04−128.57%2026-03-110.570.51−10.53%2026-02-040.130.09−30.77%2025-11-210.200.21+5.00%
About Azenta, Inc.

Azenta, Inc. is a provider of life sciences solutions specializing in cold-chain sample management and multiomics services for pharmaceutical, biotechnology, academic, and healthcare institutions worldwide. The company operates through two primary segments: Sample Management Solutions, which offers automated storage systems, cryogenic equipment, sample tubes, consumables, instruments, controlled-rate thawing devices, and biorepository services to ensure the secure handling and long-term preservation of biological and chemical samples; and Multiomics, which delivers genomic analysis including next-generation sequencing and gene synthesis through its GENEWIZ brand. Azenta supports drug development, clinical research, and advanced cell therapies by maintaining sample integrity via its global biorepository network and providing essential infrastructure for precision medicine initiatives. Notable brands under Azenta include FluidX, Ziath, 4titude, Limfinity, Freezer Pro, and Barkey, covering sample management tools, informatics, and cold-chain technologies. With operations across North America, Europe, and Asia, and headquartered in Burlington, Massachusetts, Azenta plays a critical role in the life sciences ecosystem by enabling efficient workflows for high-impact research and development programs.

Sector
Healthcare
Industry
Medical Instruments & Supplies
CEO
Mr. John P. Marotta
Employees
3,000
Headquarters
Burlington, MA, United States

Frequently asked questions about Azenta, Inc.